Key result
Thoracic epidural anesthesia as the sole anesthetic enabled complete excision of an 18-kg chest wall lipoma over 2 h in a patient with LVEF 30% with stable hemodynamics.
Why the study?
Giant chest wall lipomas are rare and pose significant perioperative and positioning challenges, while patients with severe dilated cardiomyopathy are highly vulnerable to hemodynamic instability and acute cardiac decompensation under general anesthesia.
Does thoracic epidural anesthesia with dexmedetomidine sedation provide safe and effective anesthesia for giant chest wall tumor excision in a patient with severe dilated cardiomyopathy?
Case Report (n=1)
No
Does thoracic epidural anesthesia with dexmedetomidine sedation provide safe and effective anesthesia for giant chest wall tumor excision in a patient with severe dilated cardiomyopathy?
Thoracic epidural anesthesia with dexmedetomidine sedation can serve as a safe, sole anesthetic technique that maintains hemodynamic stability during major chest wall surgery in patients with severe dilated cardiomyopathy.
Answers are grounded in this paper and cite their sources.
May support thoracic epidural as sole anesthesia in severe cardiomyopathy for chest wall surgery; leaves open need for prospective validation before wider use.
Dear Editor, We present a case demonstrating the successful use of thoracic epidural anesthesia (TEA) as the sole anesthetic technique for the excision of a giant chest wall lipoma in a patient with severe dilated cardiomyopathy (DCM). Giant lipomas of the chest wall are rare, may mimic malignant soft-tissue tumors, and often pose diagnostic and perioperative challenges.[1] A 55-year-old male weighing 55 kg had a progressively enlarging, painless mass over the left anterior chest wall for 10 years. On examination, the mass was a giant, lobulated, pedunculated swelling measuring 14.3 cm × 35.3 cm × 56.1 cm, arising from the left anterior chest wall with stretched but intact overlying skin. Its size and weight caused postural imbalance and difficulty in maintaining a stable sitting or supine position, requiring external support during positioning [Figure 1]. These factors, combined with severe DCM, contributed to significant challenges related to positioning.Figure 1: Clinical photograph of the patient demonstrating a giant chest wall lipoma presenting as a massive, pendulous swelling arising from the left anterior chest wall, extending below the waistline with stretched but intact overlying skinContrast-enhanced computed tomography confirmed a well-defined fat-attenuating lesion with internal septations and venous drainage to the axillary vein, without intrathoracic extension. Echocardiography revealed an increased left ventricular end-diastolic diameter (3.2 cm/m2), along with global hypokinesia and a severely reduced ejection fraction of 30%, consistent with severe DCM.[2] Standard American Society of Anesthesiologists monitoring and a right radial arterial line were secured. Due to the tumor’s weight, two assistants supported it to maintain a stable sitting position. Under proper aseptic precautions, a thoracic epidural was performed at the T6–T7 interspace using a midline approach and loss-of-resistance to air technique, with the patient in a supported sitting position. After negative aspiration and test dosing with 3 ml of 1.5% lignocaine, incremental dosing with 0.2% ropivacaine (5 ml + 3 ml) was done, which produced a T1–T7 sensory level. A continuous infusion of 0.1% ropivacaine (5 ml/h) and dexmedetomidine sedation (0.2–0.7 μg/kg/h) was maintained intraoperatively for sedation. Considering the large tumor mass, predicted body weight (calculated from height and sex) was used for determining doses of local anesthetics and dexmedetomidine, thereby minimizing the risk of systemic toxicity. The 18-kg tumor was excised completely over 2 h with minimal blood loss. Hemodynamic parameters remained stable throughout, with no vasopressor requirement, arrhythmias, or desaturation. Postoperative analgesia was maintained using an epidural infusion (5–6 ml/h), and recovery was uneventful. Patients with DCM have markedly reduced myocardial contractility and limited ability to compensate for perioperative stress, making them highly vulnerable to hypotension, tachyarrhythmias, pulmonary congestion, and acute cardiac decompensation under general anesthesia. Airway manipulation, positive pressure ventilation, and the myocardial depressant effects of anesthetic agents further increase the risk of hemodynamic instability in this population. In contrast, TEA provides several cardioprotective benefits by producing controlled sympathectomy, which reduces heart rate, systemic vascular resistance, and afterload, thereby improving stroke volume and myocardial oxygen balance.[3] The attenuation of the neuroendocrine stress response leads to decreased circulating catecholamines, reduced myocardial workload, and improved hemodynamic predictability throughout surgery. High thoracic epidural techniques have additionally been shown to decrease the incidence of perioperative myocardial ischemia, improve left ventricular diastolic filling, and enhance overall ventricular performance in high-risk cardiac patients undergoing major surgery.[4] While a thoracic paravertebral block can offer unilateral somatic and sympathetic blockade, its segmental spread is less reliable for extensive anterior chest wall surgery, and it lacks the broader autonomic modulation provided by TEA.[5] For large tumors requiring multidermatomal coverage and prolonged surgical duration, TEA offers more consistent sensory blockade, better control of hemodynamics, and superior intraoperative and postoperative analgesia, all of which are crucial advantages for patients with compromised cardiac function. This case highlights that TEA, when meticulously administered with appropriate monitoring, can provide safe and effective anesthesia for major chest wall surgery in carefully selected high-risk cardiac patients. Declaration of patient consent The authors certify that they have obtained all appropriate patient consent forms. In the form, the patient has given his consent for his images and other clinical information to be reported in the journal. The patient understands that name and initials will not be published and due efforts will be made to conceal identity, but anonymity cannot be guaranteed. Financial support and sponsorship Nil. Conflicts of interest There are no conflicts of interest.
No takes yet. Share an insight, caveat, or question.
Chandra et al. (2026) conducted a case report in Giant chest wall lipoma with severe dilated cardiomyopathy (DCM) (n=1). Thoracic epidural anesthesia (TEA) with ropivacaine and dexmedetomidine sedation was evaluated on Hemodynamic stability and successful tumor excision without perioperative cardiac decompensation. Thoracic epidural anesthesia as the sole anesthetic enabled complete excision of an 18-kg chest wall lipoma over 2 h in a patient with LVEF 30% with stable hemodynamics.
Synapse has enriched 10 related papers. Consider them for comparative context: